Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg(−1) rifampicin

BACKGROUND: Accumulating data indicate that higher rifampicin doses are more effective and shorten tuberculosis (TB) treatment duration. This study evaluated the safety, tolerability, pharmacokinetics, and 7- and 14-day early bactericidal activity (EBA) of increasing doses of rifampicin. Here we rep...

Descripción completa

Detalles Bibliográficos
Autores principales: te Brake, Lindsey H.M., de Jager, Veronique, Narunsky, Kim, Vanker, Naadira, Svensson, Elin M., Phillips, Patrick P.J., Gillespie, Stephen H., Heinrich, Norbert, Hoelscher, Michael, Dawson, Rodney, Diacon, Andreas H., Aarnoutse, Rob E., Boeree, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411896/
https://www.ncbi.nlm.nih.gov/pubmed/33542056
http://dx.doi.org/10.1183/13993003.00955-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411896/
https://www.ncbi.nlm.nih.gov/pubmed/33542056
http://dx.doi.org/10.1183/13993003.00955-2020

Ejemplares similares